This Master of Science program focuses on the cutting-edge field of stem cell and gene therapy, aiming to translate scientific breakthroughs into life-changing medical treatments. It's designed for individuals who want to lead in the development, manufacturing, and commercialization of these advanced therapies. The program is a collaborative effort with industry professionals, providing a comprehensive understanding of both the scientific and business aspects required to bring therapies from the laboratory to patients. Graduates will be well-prepared for careers in R&D, manufacturing, biotech entrepreneurship, and consultancy within the biopharmaceutical and advanced therapy sectors.
The MSc programme provides a blend of theoretical knowledge and practical training. Students will engage in laboratory work, research projects, and a commercialisation module with potential industrial placements. The curriculum covers key laboratory techniques, research skills, and the commercial and regulatory landscapes of advanced therapies.
Graduates are prepared for advanced roles in the cell and gene therapy and biopharmaceutical industries. The program fosters strong professional networks and practical problem-solving skills.
Candidates with relevant industrial experience are encouraged to apply. ATAS clearance may be required for students requiring a visa; processing can take up to six months. International applicants should check country-specific equivalency information.
Tuition fees are for the 2026/27 academic year.
Tuition fees for international students for the 2026/27 academic year are £50,600.
You need an upper second-class (2:2) Bachelor's degree or equivalent from a UK university or approved overseas institution in subjects like Life Sciences, Biotechnology, Bioengineering, Engineering, Chemistry, or Business with a Biotechnology component.
International applicants must achieve IELTS Level 2.
International students can apply directly through the UCL graduate application portal. It is recommended to check country-specific information and ATAS requirements early, as visa processing can take up to six months.
Graduates are prepared for roles such as R&D Scientist, Manufacturing Scientist, Management Consultant, Business Analyst, Marketing Professional, Biotech Entrepreneur, and Regulatory Affairs Specialist within the cell and gene therapy and biopharmaceutical industries.
Yes, the programme is co-designed with industry professionals and offers guest lectures, site visits, research placements, and mentoring with direct industry access.